{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:16Z","timestamp":1707525256120},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,19]]},"DOI":"10.7759\/cureus.43746","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T11:39:57Z","timestamp":1692445197000},"source":"Crossref","is-referenced-by-count":0,"title":["Triggered: Discovery of Neurocysticercosis Following Self-Administered Albendazole"],"prefix":"10.7759","author":[{"given":"William R","family":"Southall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelaine S","family":"Southall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad B","family":"Aldaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwanath","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phani V","family":"Akella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"CDC. Parasites - cysticercosis. (2023). Accessed. July 13, 2023: https:\/\/www.cdc.gov\/parasites\/cysticercosis\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001152","article-title":"Clinical manifestations associated with neurocysticercosis: a systematic review","volume":"5","author":"Carabin H","year":"2011","unstructured":"Carabin H, Ndimubanzi PC, Budke CM, et al.. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011, 5:e1152. 10.1371\/journal.pntd.0001152","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia HH","year":"2014","unstructured":"Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014, 13:1202-15. 10.1016\/S1474-4422(14)70094-8","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1645\/0022-3395(2002)088[0069:TEIOPW]2.0.CO;2","article-title":"The experimental infection of pigs with different numbers of Taenia solium eggs: immune response and efficiency of establishment","volume":"88","author":"Santamar\u00eda E","year":"2002","unstructured":"Santamar\u00eda E, Plancarte A, de Aluja AS. The experimental infection of pigs with different numbers of Taenia solium eggs: immune response and efficiency of establishment. J Parasitol. 2002, 88:69-73. 10.1645\/0022-3395(2002)088[0069:TEIOPW]2.0.CO;2","journal-title":"J Parasitol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0037-198x(97)80025-9","article-title":"Computed tomography and magnetic resonance imaging of neurocysticercosis","volume":"32","author":"Palacios E","year":"1997","unstructured":"Palacios E, Salgado Lujambio P, Rojas Jasso R. Computed tomography and magnetic resonance imaging of neurocysticercosis. Semin Roentgenol. 1997, 32:325-34. 10.1016\/s0037-198x(97)80025-9","journal-title":"Semin Roentgenol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-706x(03)00057-3","article-title":"Imaging findings in neurocysticercosis","volume":"87","author":"Garc\u00eda HH","year":"2003","unstructured":"Garc\u00eda HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003, 87:71-8. 10.1016\/s0001-706x(03)00057-3","journal-title":"Acta Trop"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2005.11.016","article-title":"Clinical aspects of neurocysticercosis","volume":"55","author":"Takayanagui OM","year":"2006","unstructured":"Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int. 2006, 55:S111-5. 10.1016\/j.parint.2005.11.016","journal-title":"Parasitol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-88751","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"98","author":"White AC Jr","year":"2018","unstructured":"White AC Jr, Coyle CM, Rajshekhar V, et al.. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2018, 98:945-66. 10.4269\/ajtmh.18-88751","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000371","article-title":"Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures","volume":"3","author":"Lescano AG","year":"2009","unstructured":"Lescano AG, Garcia HH, Gilman RH, et al.. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis. 2009, 3:e371. 10.1371\/journal.pntd.0000371","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia HH","year":"2004","unstructured":"Garcia HH, Pretell EJ, Gilman RH, et al.. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004, 350:249-58. 10.1056\/NEJMoa031294","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial","volume":"79","author":"Carpio A","year":"2008","unstructured":"Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, Hauser WA. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008, 79:1050-5. 10.1136\/jnnp.2008.144899","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4891-5","article-title":"Quantitative assessment of lesion load and efficacy of 3\u2009cycles of albendazole in disseminated cysticercosis: a prospective evaluation","volume":"20","author":"Pandey S","year":"2020","unstructured":"Pandey S, Malhotra HS, Garg RK, et al.. Quantitative assessment of lesion load and efficacy of 3\u2009cycles of albendazole in disseminated cysticercosis: a prospective evaluation. BMC Infect Dis. 2020, 20:220. 10.1186\/s12879-020-4891-5","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial","volume":"14","author":"Garcia HH","year":"2014","unstructured":"Garcia HH, Gonzales I, Lescano AG, et al.. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014, 14:687-95. 10.1016\/S1473-3099(14)70779-0","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.86","article-title":"Corticosteroid use in neurocysticercosis","volume":"11","author":"Nash TE","year":"2011","unstructured":"Nash TE, Mahanty S, Garcia HH. Corticosteroid use in neurocysticercosis. Expert Rev Neurother. 2011, 11:1175-83. 10.1586\/ern.11.86","journal-title":"Expert Rev Neurother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.03.013","article-title":"Antiparasitic treatment of neurocysticercosis - the effect of cyst destruction in seizure evolution","volume":"76","author":"Garcia HH","year":"2017","unstructured":"Garcia HH, Del Brutto OH. Antiparasitic treatment of neurocysticercosis - the effect of cyst destruction in seizure evolution. Epilepsy Behav. 2017, 76:158-62. 10.1016\/j.yebeh.2017.03.013","journal-title":"Epilepsy Behav"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12739","article-title":"Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after","volume":"55","author":"Garcia HH","year":"2014","unstructured":"Garcia HH, Gonzales I, Lescano AG, Bustos JA, Pretell EJ, Saavedra H, Nash TE. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia. 2014, 55:1452-9. 10.1111\/epi.12739","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20172729","article-title":"Adverse events of albendazole due to mass drug administration","volume":"6","author":"Agrawal P","year":"2017","unstructured":"Agrawal P, Srivastava B, Bhardwaj R, Gaur S. Adverse events of albendazole due to mass drug administration. Int J Basic Clin Pharmacol. 2017, 6:1674-7. 10.18203\/2319-2003.ijbcp20172729","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.02.004","article-title":"Empiric albendazole therapy and new onset seizures--a cautionary note","volume":"60","author":"Lillie P","year":"2010","unstructured":"Lillie P, McGann H. Empiric albendazole therapy and new onset seizures--a cautionary note. J Infect. 2010, 60:403-4. 10.1016\/j.jinf.2010.02.004","journal-title":"J Infect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc062891","article-title":"Neurocysticercosis uncovered by single-dose albendazole","volume":"356","author":"Garcia HH","year":"2007","unstructured":"Garcia HH, Gonzalez I, Mija L. Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med. 2007, 356:1277-8. 10.1056\/NEJMc062891","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/176658-triggered-discovery-of-neurocysticercosis-following-self-administered-albendazole","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:05Z","timestamp":1707508985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/176658-triggered-discovery-of-neurocysticercosis-following-self-administered-albendazole"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.43746","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,19]]}}}